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Transient transfection of chemically synthesized microRNA (miRNA) mimics is being used
extensively to study the functions and mechanisms of endogenous miRNAs. However, it
remains unclear whether transfected miRNAs behave similarly to endogenous miRNAs.
Here we show that transient transfection of miRNAmimics into HeLa cells by a commonly
used method led to the accumulation of high molecular weight RNA species and a
few hundred fold increase in mature miRNA levels. In contrast, expression of the same
miRNAs through lentiviral infection or plasmid transfection of HeLa cells, transgenic
expression in primary lymphocytes, and endogenous overexpression in lymphoma and
leukemia cell lines did not lead to the appearance of high molecular weight RNA species.
The increase of mature miRNA levels in these cells was below 10-fold, which was
sufficient to suppress target gene expression and to drive lymphoma development
in mice. Moreover, transient transfection of miRNA mimics at high concentrations
caused non-specific alterations in gene expression, while at low concentrations achieved
expression levels comparable to other methods but failed to efficiently suppress target
gene expression. Small RNA deep sequencing analysis revealed that the guide strands
of miRNA mimics were frequently mutated, while unnatural passenger strands of
some miRNA mimics accumulated to high levels. The high molecular weight RNA
species were a heterogeneous mixture of several classes of RNA species generated
by concatemerization, 5′- and 3′-end tailing of miRNA mimics. We speculate that the
supraphysiological levels of mature miRNAs and these artifactual RNA species led to
non-specific changes in gene expression. Our results have important implications for
the design and interpretation of experiments primarily employing transient transfection of
miRNA mimics.
Keywords: transient transfection, microRNA mimics, miR-17∼92, miR-155, high molecular weight RNA species,
guide strand mutation, unnatural passenger strand
INTRODUCTION
MicroRNAs (miRNAs) are endogenously encoded single stranded RNAs of about 22 nucleotides
(nts) in length that play essential roles in a large variety of physiological processes (Ambros, 2004;
Bushati and Cohen, 2007; Krol et al., 2010; Palanichamy and Rao, 2014). During their biogenesis,
miRNA genes produce nascent transcripts with stem-loop structures (pri-miRNAs), which are
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processed sequentially by the Drosha-DGCR8 complex and
Dicer to yield mature miRNA duplexes (miRNA/miRNA∗) (Kim
et al., 2009). These miRNA duplexes are subsequently integrated
into RNA-induced silencing complexes (RISC), whose core
component is one of the Argonaute family proteins (AGO1-
4) in mammalian cells. Once a miRNA duplex is loaded,
RISC quickly removes the passenger strand (miRNA∗) either
by cleavage or by an unwinding and release process (Ha and
Kim, 2014). The guide strand directs RISC to target mRNAs,
which are recognized through partial sequence complementarity
via the seed sequence located at nucleotide positions 2–8 of
the mature miRNA. The functional consequences of miRNA-
target mRNA interactions can be translation repression, mRNA
degradation, or both (Fabian et al., 2010;Wilczynska and Bushell,
2015). The molecular mechanisms underlying these two distinct
functional consequences have been under extensive investigation
but remain unresolved (Jin and Xiao, 2015; Jonas and Izaurralde,
2015).
MiRNA mimics are chemically synthesized double-stranded
RNA molecules imitating mature miRNA duplexes. Chemical
modifications not present in endogenous miRNAs (Wang, 2011;
Thomson et al., 2013), as well as nucleotide changes in the
passenger strands (Lim et al., 2005; Garcia et al., 2011), are
often introduced to miRNA mimics to improve their stability,
to facilitate guide miRNA loading to RISC, and to selectively
exclude the passenger strand. Delivery of miRNA mimics into
cells can bypass the endogenous miRNA biogenesis pathway
and alter miRNA abundance instantly. Transient transfection
can efficiently deliver miRNA mimics into in vitro cultured
mammalian cells, and has been taken for granted as a fast, easy,
and economical way to gain insights into the functions and
mechanisms of action of endogenous miRNAs. However, the
proprietary chemical modifications and formulations of miRNA
mimics are often not disclosed to users, thereby increasing the
chance of performing misleading experiments (Git, 2012). Also,
the mechanisms of action of chemically synthesized miRNA
mimics presumably recapitulate that of endogenous miRNAs,
but supporting evidence is quite limited despite their widespread
use. Thus, a recent study employing this approach led to the
conclusion that miRNAs predominantly act to decrease target
mRNA levels rather than decreasing translation efficiency (Guo
et al., 2010). By contrast, analyses of select sets of functionally
relevant target genes in mice with loss- and gain-of function
mutations for individual miRNA genes often showed significant
changes in protein concentrations, but with marginal or no
alterations in mRNA levels (Zhao et al., 2005, 2007; Lu et al.,
2007, 2009; Vigorito et al., 2007; Van Rooij et al., 2007; Dorsett
et al., 2008; Boettger et al., 2009; Callis et al., 2009; O’connell
et al., 2009, 2010; Williams et al., 2009; Biton et al., 2011; Boldin
et al., 2011; Liu et al., 2011; Ma et al., 2011; Sanuki et al.,
2011; Shibata et al., 2011; Bian et al., 2013; Danielson et al.,
2013; Hasuwa et al., 2013; Henao-Mejia et al., 2013; Stadthagen
et al., 2013; Wang et al., 2013, 2015; Agudo et al., 2014),
corroborating the initial findings in the field that miRNAs repress
the protein output of target genes without significantly effecting
their mRNA levels in animals (Lee et al., 1993; Wightman et al.,
1993).
We speculated that the discrepancy between these two types
of studies regarding the predominant mechanism of miRNA
action stems from the transient transfection approach, which
may not recapitulate the actions of endogenous miRNAs under
physiological conditions (Jin and Xiao, 2015). To address this
issue, we performed transient transfection of mimics of several
oncogenic miRNAs into HeLa cells following commonly used
experimental conditions, and examined their expression levels
over time by Northern blot. In addition, we compared the effect
of transient transfection of miRNAmimics on target gene mRNA
and protein levels with the effect of lentiviral expression, plasmid
transfection and transgenic expression of the same miRNAs. We
also performed small RNA deep sequencing analysis of cells
transiently transfected with miRNA mimics to determine the
exact sequences of RNA species arising from these mimics. Our
results have profound implications for the design of miRNA
experiments and for the interpretation of experimental results
from studies predominantly relying on the transient transfection
approach.
MATERIALS AND METHODS
Mice and Ethics Statement
The generation of miR-17∼92 Tg (Jax stock 008517), CD19-Cre
(CD19cre/+) (Jax stock 006785), and miR-155 transgenic mice
was previously reported (Rickert et al., 1997; Costinean et al.,
2006; Xiao et al., 2008). MiR-17∼92 Tg mice were crossed with
CD19-Cre mice to generate miR-17∼92 Tg/Tg; CD19-Cre (TG)
mice (Jin et al., 2013). CD19-Cre mice were used as control.
All animal experiments were approved by Animal Care and Use
Committee of The Scripps Research Institute.
Purification of B Cells and In vitro
Stimulation
Spleen and peripheral lymph nodes were collected from 8-week-
old mice of indicated genotypes. Primary B cells were purified
by depleting cells positive for AA4.1 (CD93, eBioscience- 13-
5892-85), CD43 (DB Pharmingen- 553269), or CD5 (BioLegend-
100604) using MACS LD columns (Miltenyi Biotec) following
manufacturer’s instructions. The purified B cells were cultured
at 5 × 106 cells/ml, and rested for 3 h before harvesting (naïve)
or activated for indicated amounts of time with 2µg/ml anti-
IgM (for miR-17∼92 transgenic B cells) or 25µg/ml LPS and
5 ng/ml IL-4 (for miR-155 transgenic B cells) in 37◦C cell culture
chambers. At the time of harvesting, live cells were purified using
Ficoll following manufacturer’s instructions (GE Healthcare,
Ficoll Paque PLUS, 17-1440-02), achieving >90% viability and
>98% B cell purity (B220+ CD19+).
Cell Culture
HeLa cells were cultured in DMEM with glutamax (Dulbeccos’s
modified eagle medium with glutamax, Gibco 10569)
supplemented with 10% fetal bovine serum and 1% of 100
units/ml penicillin/streptomycin (100x stock). The OCI-Ly3,
OCI-Ly1, and OCI-Ly19 cell lines were obtained from Dr.
Minden (University of Toronto) and cultured in Iscove’s
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Modified Dulbecco’s Medium (Life Technologies) containing
20% Fetal Bovine Serum (FBS; HyClone), and 100 units/ml
penicillin and 100µg/ml streptomycin (Gibco). The BJAB,
Ramos, Raji, SU-DHL-4 cell lines were obtained from the
American Type Culture Collection (ATCC) and cultured
in RPMI 1640 Medium containing 2mM L-Glutamine
(Gibco), 10% FBS, and 100 units/ml penicillin and 100µg/ml
streptomycin. All human lymphoma cell lines were cultured
to approximately 1 × 106 cell/ml at 37◦C with 5% CO2 in
T-175 flasks. Cells were removed, centrifuged (7min, 270 rcf),
and resuspended in PBS buffer (Corning Cellgro). Cells were
counted, and 1.8× 107 cells were centrifuged. Following removal
of the supernatant, cell pellets were frozen at−80◦C until further
processing for Northern blot.
Transient Transfection of miRNA Mimics
5 × 105 HeLa cells were seeded in 60mm plates 18–24 h prior
to transfection. Media were replaced with antibiotics-free media
6–12 h before transfection. Synthetic miRNA mimics (from
Dharmacon or Shanghai GenePharma) were transfected into cells
following the Dharmafect1 transfection protocol (T-2001-03).
Twenty-four hours later, cells were split into two 60mm plates
in antibiotics-containing media and cultured for an additional
48 h. Cells were then washed twice with PBS and lysed in TRIzol
reagent (Life Technology, #15596) or in 1% NP-40 lysis buffer
containing 1% Nonidet P-40, 150mM NaCl, 50mM Tris-Cl (pH
8.0), 1mM sodium orthovanadate, 1mM DTT and proteinase
inhibitors (halt inhibitor, Thermo #78442) for total RNA and
protein extraction, respectively.
Synthetic miRNA Mimics
The following synthetic miRNA mimics were used in this study:
Mimic Transfection Control with Dy547 (cel-mir-67 conjugated
with Dy547), Dharmacon CP-004500-01-10
miRIDIAN microRNA Mimic Negative Control #1 (cel-mir-67),
Dharmacon CN-001000-01-10
miRIDIANMimic hsa-miR-17, Dharmacon C-300485-05-0005
miRIDIANMimic hsa-miR-18a, Dharmacon C-300487-05-0005
miRIDIANMimic hsa-miR-19a, Dharmacon C-300488-03-0005
miRIDIANMimic hsa-miR-20a, Dharmacon C-300491-03-0005
miRIDIANMimic hsa-miR-19b, Dharmacon C-300489-03-0005
hsa-miR-92a, custom synthesized by Shanghai GenePharma
miRIDIANMimic hsa-miR-155, Dharmacon C-300647-05-0010
Stable Cell Line Generation
Generation of miR-17∼92-expressing lentivirus was previously
described (Hong et al., 2010). HeLa cells were seeded in 48-well
plates at a density of 5 × 103 cells/well on the afternoon prior to
transduction with control or miR-17-92-expressing lentiviruses
(LV-Control and LV-miR-17∼92, respectively). On the afternoon
of the following day, different amounts of LV-Control or LV-miR-
17∼92 lentiviruses corresponding to multiplicities of infection
(MOI) 10, 20, 50, and 100 were added to cells and overnight
infection was performed in the presence of 8µg/ml polybrene.
Media was replaced 16 h after adding viruses. Transduction
efficiency was monitored by flow cytometry analysis of GFP,
which is encoded by lentiviruses. Transduced cells were further
expanded to generate low-passage stocks of stable cell lines.
Plasmid Transfection
Transfection of miR-17∼92-expresing plasmid was previously
described (Xiao et al., 2008). Briefly, 2 × 105 HeLa cells were
plated into 12 well plates 24 h before transfection. At 70%
confluency, 0.4µg of miR-17∼92-expressing pCNX2 plasmid
(Plasmid-miR-17∼92) or empty pCNX2 plasmid (Plasmid-
Empty) were transfected into each well using FugeneHD
(Promega #E2311) following manufacturer’s instructions. The
miR-17∼92-expressing-lentivirus (LV-miR-17∼92), plasmid
(Plasmid-miR-17∼92), and transgene (TG) used in this study all
contain the same insert, a 1007 bp fragment of human genomic
DNA encoding miR-17∼92 (human chr13: 91350568–91351574)
(Xiao et al., 2008).
Northern Blot
MiRNA Northern blot was performed as described previously
(Xiao et al., 2007, 2008). First, 20µg TRIzol-extracted total
RNA in less than 10µl RNase-free water was mixed with
20µl Gel Loading Buffer II (Ambion, #8547). This loading
buffer contains 95% formamide, 18mM EDTA and 0.025%
SDS, therefore efficiently denatures potential RNA duplexes.
The samples were further denatured at 95◦C for 5min and
immediately cooled down on ice to prevent re-annealing. The
denatured RNA samples were separated on 10% denaturing
polyacrylamide gels. The gel was made as the following: 16.8 g
urea, 4ml of 5x TBE solution (27 g Tris Base, 13.7 g boric acid,
10ml of 0.5M EDTA pH 8.0, fill up DEPC water to 500ml), and
16ml DEPC water were mixed and heated to 70◦C for 20min to
dissolve urea completely. The solution was cooled down at room
temperature. Then 10ml 40% (w/v) Acrylamide/Bis-Acrylamide
37.5:1 solution (Bioworld, 40120040-3) was added to make a
total of 40ml solution. Finally, 240µl of 10% APS and 32µl
TEMED were added and mixed before pouring into RNase-free
gel cassettes (18 cm × 16 cm). Once the gel was solidified, the
samples were separated in 0.5x TBE buffer with constant power
(5 W) until the bromophenol blue dye from the Gel Loading
Buffer II reached about 4 cm to the end of the gel. The gel was
electrotransfered to a positively charged nylon membrane (GE
Healthcare, Amersham Hybond-N+, RPN2020b) for 8–10 h in
a cold room at constant voltage (30V) in 0.5x TBE buffer with
stirring. The transferred membranes were briefly washed with
0.5x TBE buffer, dried on Whatman paper for 10min, and UV-
cross-linked to fix the transferred RNAs to the membrane. For
miRNA detection, DNA oligonucleotides antisense to mature
miRNAs were purchased from Integrated DNA Technologies
(Coralville, IA) and used as probes. The synthesized DNA
oligos were 5′-end labeled using γ-32P ATP (Perkin Elmer,
BLU002A100UC) with T4 Polynucleotide Kinase (NEB,M0201S)
following manufacturer’s instructions. The labeled oligos were
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purified using MicroSpin G25 column (GE Healthcare, 27-5325-
01). miRNA signals were detected with probes for individual
miRNAs, or a mixture of probes detecting all members of a
miRNA subfamily (i.e., miR-17 subfamily). For example, the
probe mixture for the miR-17 subfamily contains probes for
miR-17, miR-20a, miR-106a, miR-20b, miR-106b, and miR-93,
the probe mixture for the miR-18 subfamily contains probes
for miR-18a and miR-18b, the probe mixture for the miR-19
subfamily contains probes for miR-19a and miR-19b, and the
probe mixture for the miR-92 subfamily contains probes for miR-
92, miR-363, and miR-25. U6 snRNA was used as an internal
control for normalization. The purified probes were pre-heated
in hybridization buffer (40ml of 5M NaCl, 10ml of 1M Tris, pH
7.5, 20 g of Dextran sulfate sodium salt, 10ml of 20% (w/v) SDS,
5ml of sonicated salmon sperm DNA (10mg/ml), and 135ml
water with a final volume of 200ml) at 65◦C. The membranes
were pre-hybridized with the hybridization buffer for 2–3 h
and hybridized with pre-heated probes at 42◦C overnight. The
hybridized membranes were washed with Buffer I (2x SSC, 0.1%
SDS) and Buffer II (1x SSC, 0.1% SDS) at room temperature
for 30min each. Additional washing with Buffer III (0.5x SSC,
0.1% SDS) was included when the background signals were high.
The membranes were exposed to a phospho-screen, which was
subsequently scanned on a STORM 860 phosphorimager. Data
were analyzed using the ImageQuant software.
miRNA Mature Northern blot probes (seed
subfamily miRNAs sequences are underlined)
miR-17 subfamily: miR-17-5p ACT ACC TGC ACT GTA AGC ACT TTG
miR-20a CTA CCT GCA CTA TAA GCA CTT TA
miR-106a CTA CCT GCA CTG TTA GCA CTT TG
miR-20b CTA CCT GCA CTA TGA GCA CTT TG
miR-106b ATC TGC ACT GTC AGC ACT TTA
miR-93 CTA CCT GCA CGA ACA GCA CTT TG
miR-18 subfamily: miR-18a CTA TCT GCA CTA GAT GCA CCT TA
miR-18b CTA ACA GCA CTA GAT GCA CCT TA
miR-19 subfamily: miR-19a TCA GTT TTG CAT AGA TTT GCA CA
miR-19b TCA GTT TTG CAT GGA TTT GCA CA
miR-92 subfamily: miR-92 CAG GCC GGG ACA AGT GCA ATA
miR-363 TAC AGA TGG ATA CCG TGC AAT T
miR-25 TCA GAC CGA GAC AAG TGC AAT G
miR-155 miR-155 CCC CTA TCA CAA TTA GCA TTA A
Antisense miR-17 n.a AAC AAA GTG CTT ACA GTG
cel-mir-67 cel-mir-67 TCT ACT CTT TCT AGG AGG TTG TGA
U6 snRNA (control) n.a TAT GTG CTG CCG AAG CGA GCA C
Western Blot
HeLa cells were lysed in 1% NP-40 lysis buffer containing 1%
Nonidet P-40, 150mM NaCl, 50mM Tris-Cl (pH 8.0), 1mM
sodium orthovanadate, 1mM DTT and proteinase inhibitors
(halt inhibitor, Thermo #78442), and subjected to separation on
8 or 10% SDS-PAGE gels and Western blot (10µg whole cell
lysate per lane). Antibodies used for Western blot were anti-Bim
(Cell Signaling, 2933), anti-Pten (Cell Signaling, 9559), anti-
Phlpp2 (Bethyl, A300-661A-1), and anti-Ship1 (Cell Signaling,
2728).
Real-time PCR
Total RNA was prepared and extracted as described above.
cDNA libraries were generated using 1µg total RNA with
an iScript cDNA Syntehesis Kit (Bio-Rad, 170-8891), whose
premix contains both random hexamer and oligo-dT primers.
The subsequent quantitative PCR analysis was performed
with Maxima SYBR Green/Rox Master Mix (Thermo, K0223)
and gene specific primers. The reaction mixture was initially
denatured for 10min at 95◦C, followed by 40 PCR cycles. Each
PCR cycle consists of a denaturing step (95◦C for 15 s) and a
primer annealing/extension step (60◦C for 60 s). The primers
used in this study are:
human Actb(F): 5′-ACCTTCTACAATGAGCTGCG-3′
human Actb(R): 5′-CCTGGATAGCAACGTACATGG-3′
human Phlpp2(F): 5′-TGGAACACAAGACACTGGAC-3′
human Phlpp2(R): 5′-AGCTTATTTCTCTGCCCTGC-3′
human Pten(F): 5′-AAGGGACGAACTGGTGTAATG-3′
human Pten(R): 5′-GCCTCTGACTGGGAATAGTTAC-3′
human Bim(F): 5′-TCGGACTGAGAAACGCAAG-3′
human Bim(R): 5′-CTCGGTCACACTCAGAACTTAC-3′
human Isg15(F): 5′-ACTCATCTTTGCCAGTACAGG-3′
human Isg15(R): 5′-CAGCTCTGACACCGACATG-3′
human Oas1(F): 5′-CATCTGTGGGTTCCTGAAGG-3′
human Oas1(R): 5′-GAGAGGACTGAGGAAGACAAC-3′
human Ifna2(F): 5′-CCCATTTCAACCAGTCTAGCAG-3′
human Ifna2(R): 5′-TGTGGGTTTGAGGCAGATC-3′
human Ifnb1(F): 5′-AGGATTCTGCATTACCTGAAGG-3′
human Ifnb1(R): 5′-GGCTAGGAGATCTTCAGTTTCG-3′
human Mx1(F): 5′-GAAGATAAGTGGAGAGGCAAGG-3′
human Mx1(R): 5′-CTCCAGGGTGATTAGCTCATG-3′
human Eif2ak2(F): 5′-CGATACATGAGCCCAGAACAG-3′
human Eif2ak2(R): 5′-AGAATTAGCCCCAAAGCGTAG-3′
human Tlr3(F): 5′-TCAACTTTCTGATAAAACCTTTGCC-3′
human Tlr3(R): 5′-AGATGACAAGCCATTATGAGACA-3′
human Cxcl10(F): 5′-CCTTATCTTTCTGACTCTAAGTGGC-3′
human Cxcl10(R): 5′-ACGTGGACAAAATTGGCTTG-3′
human Irf7(F): 5′-TCCCCACGCTATACCATCTAC-3′
human Irf7(R): 5′-GAAGACACACCCTCACGC-3′
murine Actb(F): 5′-CTAAGGCCAACCGTGAAA G-3′
murine Actb(R): 5′-ACCAGAGGCATACAGGGACA-3′
murine Phlpp2(F): 5′-ATCTGGTCAGGAGACTGG A-3′
murine Phlpp2(R): 5′-GGATTCGATCCAGATGATCCA-3′
murine Pten(F): 5′-TGGGGAAGTAAGGACCAGAG-3′
murine Pten(R): 5′-GGCAGACCACAAACTGAGGA-3′
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murine Bim (F):5′-gagatacggattgcacaggag-3′
murine Bim (R): 5′-cggaagataaagcgtaacagttg-3′
Differential expression was calculated according to the 11CT
method.
Small RNA Deep Sequencing
Sample Preparation
1µg total RNA from non-transfected HeLa cells and HeLa
cells transfected with an equal molar mixture of miR-17,
18a, 19a, 20a, 19b, and 92a (16.7 nM each with a total
transfection concentration of 100 nM) was used for Next
Generation Sequencing following the standard Illumina protocol,
TruSeq_SmallRNA_SamplePrep_Guide_15004197_C.pdf, using
12 cycles of PCR.
3′ Adapter Ligation
10 pmol of 3′-adenylated DNA adapter (5′-AppTGGAATT
CTCGGGTGCCAAGGddC) is combined with 1µg total RNA
in a 4µl volume, heated to 70◦C for 2min and then placed on
ice. In a separate tube, 2µl 10X T4 RNA Ligase 2 Truncated
reaction buffer (NEB), 2µl 50% PEG8000 (NEB), 1µl RNase
OUT (Lifetech) and 1µl T4 RNA Ligase 2 Truncated enzyme
(NEB) were combined and added to the RNA/3′adapter mix and
incubated at 28◦C for 1 h. This mixture was then heated to 70◦C
for 2min.
5′ Adapter Ligation
1µl water, 1µl 10mM ATP, 1µl T4 RNA Ligase and 1µl 5′
RNA adapter (25 pmol, 5′-GUUCAGAGUUCUACAGUCCGAC
GAUC) were added and incubated at 28◦C for 1 h.
Reverse Transcription
1µl of a 10µM solution of RT primer (5′-GCCTTGGCACCC
GAGAATTCCA) was added to 6µl of the 5′ adapter ligation mix
above, heated to 70◦C for 2min and then transferred to ice. This
was then combined with a solution containing 2µl of 5x First
Strand Buffer (Superscript II buffer, Lifetech), 0.5µl of 12.5mM
dNTPs, 1µl 0.1M DTT, 1µl RNaseOUT (Lifetech), and 1µl
Superscript II (200U/µl). The reaction was incubated at 50◦C for
1 h and then placed on ice.
cDNA Library Synthesis
The 12.5µl reverse transcription reaction above was
added to a tube containing: 30 pmol of Illumina Truseq
Universal PCR primer (5′-AATGATACGGCGACCACCGA
GATCTACACGTTCAGAGTTCTACAGTCCGA); 30 pmol of
Illumina Truseq Barcoded PCR primer (5′-CAAGCAGAAG
ACGGCATACGAGATXXXXXXGTGACTGGAGTTCCTTGGC
ACCCGAGAATTCCA, in which XXXXXX corresponds to
standard Illumina Truseq barcodes); and 25µl of 2x KAPA
HiFi HotStart ReadyMix PCR Kit in a total volume of 50µl.
The reaction was heated to 98◦C for 1min, and then cycled
12 times with 98◦C for 10 s, 60◦C for 30 s, and 72◦C for 15 s,
followed by a single incubation at 72◦C for 5min. The resulting
PCR products were isolated using AMPure XP PCR purification
system (Agencourt, Beckman-Coulter), separated on a 4%
Agarose gel, with PCR products cut in the 140–195 bps range,
which corresponds to insert size of 20–75 bps. Library was
extracted from the gel using Zymo agarose dissolve buffer (ADB)
as specified by the Zymo manual and then run over a Zymo
DNA Clean & Concentrator-25 column to purify. The prepared
library was then loaded onto an Illumina NextSeq500 flowcell,
sequenced for 75 bases of the insert and 7 bases of the index read
using standard NextSeq500 sequencing reagents. Reads were
then processed using CASAVA 1.8 and demultiplexed based on
index sequences.
Data Processing and Bioinformatic Analysis
Raw reads were preprocessed to remove the adaptors using
cutadapt (Martin, 2011). Reads shorter than 15 nucleotides or
longer than 80 nucleotides were discarded. Next, reads were
aligned to the pre-built Bowtie indexed human genome, H.
Sapiens UCSC hg19, using Bowtie short read aligner (http://
bowtie-bio.sourceforge.net/index.shtml), and rRNA species
were removed. The remaining non-rRNA reads were examined
for quality control using FastQC software (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/). The highly
enriched reads (greater than 0.1% of total reads) were selected
for further analysis. For each sample, known miRNAs were
identified and enumerated using miRDeep2 software package
(Friedländer et al., 2008). To analyze high molecular weight
RNA species, reads between 25 and 74 nt were pre-selected and
analyzed by ShortRead and Biostrings library from Bioconductor
in R (Morgan et al., 2009). To isolate RNA species containing a
string of mature miR-17∼92 or mutated miR-17∼92 sequences,
vcountPattern function with max.mismatch= 5, with.indels= T
option was used. The length distribution plot was generated using
custom scripts in R. miRNA sequencing results are available in
the NCBI Gene Expression Omnibus (GEO) database under the
series accession identifier GSE73099.
RESULTS
Dose–dependent Effect of miRNA Mimics
on Cell Survival
We first examined the efficiency and dynamic range of transient
transfection of miRNA mimics, following commonly used
experimental conditions (Lim et al., 2005; Grimson et al., 2007;
Baek et al., 2008; Selbach et al., 2008; Guo et al., 2010). We
transfected HeLa cells with a C. elegans miRNA (cel-mir-67)
conjugated with the Dy547 fluorophore at graded concentrations.
The mature cel-mir-67 sequence bears no similarity with
any mouse or human miRNAs and, therefore, is suitable for
quantification. For the purpose of titrating, we tested a broad
range of miRNA mimic concentrations (0.1–300 nM), including
two concentrations that have been frequently used in various
miRNA mechanism studies: 25 nM (Grimson et al., 2007; Baek
et al., 2008) and 100 nM (Lim et al., 2005; Selbach et al.,
2008; Guo et al., 2010). As shown in Figure 1A, transient
transfection of miRNA mimic is very efficient, with measurable
Dy547 signals at 0.5 nM. At higher concentrations the whole
cell population was shifted toward a positive Dy547 signal,
suggesting high transfection efficiency (Figure 1A). We observed
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FIGURE 1 | Transient transfection of cel-mir-67 into HeLa cells. (A) HeLa cells were transfected with indicated concentrations of Dy547-conjugated cel-mir-67.
Dy547 signals were analyzed by flow cytometry at 24 h post-transfection. (B) Correlation summary of Dy547 mean fluorescence intensity (MFI) and transfection
concentrations of cel-mir-67. (C) Live cell percentage was determined by trypan blue staining of cells transfected with indicated concentrations of Dy547-conjugated
cel-mir-67 at indicated time points. (D) Growth curves of HeLa cells transfected with indicated concentrations of cel-mir-67. (E–G) HeLa cells transfected with 100 nM
Dy547-conjugated cel-mir-67 and Dy547 signals were analyzed by flow cytometry at indicated time points after transfection (E). Dy547 MFI was plotted against time
to calculate its half-life (F). Dy547 MFI in (F) was normalized to cell division (G). Mock, HeLa cells transfected with 100 nM un-conjugated cel-mir-67.
an excellent dose-dependent response of Dy547 signal to
transfection concentration of miRNA mimic without saturation
at the highest concentration tested (300 nM), suggesting that the
amount of miRNA mimic introduced into cultured cells can be
controlled simply by adjusting the transfection concentration
(Figure 1B). However, when transfected with a miRNA mimic
at 150 nM or higher concentration, a significant fraction of
cells started to die at 24 h post-transfection and viable cultures
could not be maintained after that (Figure 1C). This suggests a
limit to the amount of miRNA mimic that can be introduced
into cultured cells. Moreover, cell growth was significantly
retarded upon miRNA mimic transfection at 5 nM or higher
concentrations (Figure 1D). Therefore, we decided to focus on
100 nM, a concentration frequently used in the literature (Lim
et al., 2005; Selbach et al., 2008; Guo et al., 2010), in the following
study.
Next we investigated the turnover time of transfected miRNA
mimics by following the Dy547 signal in transfected cells for up
to 72 h. At the 100 nM transfection concentration, the cellular
miRNA mimic level peaked around 12 h, followed by a steady
decrease over time, with a half-life of 28 h (Figures 1E–G). As the
average doubling time of HeLa cells is 23 h (Jacobson and Ryan,
1982), the decrease in cellular miRNA mimic concentration is
likely caused by cell division instead of active miRNA decay
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pathways (Figure 1F). Indeed, after normalizing the cellular
levels of transfected cel-mir-67 to the doubling time of HeLa cells
to remove the dilution effect caused by cell division, we found no
active decay of the transfected cel-mir-67 (Figure 1G).
Transfection of miRNA Mimics at High
Concentrations Leads to
Supraphysiological miRNA Levels and
Accumulation of High Molecular Weight
RNA Species
To follow the behavior of transiently transfected miRNA mimic
in cells in further details, we performed Northern blot analysis
of HeLa cells transfected with 100 nM cel-mir-67 (without
Dy547 conjugation) at various time points after transfection.
As shown in Figure 2A, cel-mir-67 accumulated to significant
levels as early as 30min post-transfection, peaked at 3–6 h,
and decreased drastically after 24 h. Strikingly, we observed the
accumulation of RNA species larger than mature cel-mir-67,
whose concentrations mirror that of mature cel-mir-67. These
RNA species must be byproducts of transfected cel-miR-67,
as they hybridized with the Northern blot probe, a cel-miR-
67 antisense DNA oligonucleotide, and were absent in non-
transfected HeLa cells and L1236 cells, a human Hodgkin’s
lymphoma cell line. Importantly, transient transfection of cel-
mir-67 did not alter the expression level and size of endogenous
miRNAs, including miR-17, miR-18a, miR-19b, miR-92a, and
miR-16 (Figure 2B). Next, we estimated the copy numbers of
cel-mir-67 mimic in transfected HeLa cells by comparing to
graded amounts of the same miRNA mimic loaded directly into
the Northern blot gel. Strikingly, transient transfection delivered
0.3 million copies of miRNA mimic per cell in 30min post-
transfection and this number reached 1.8 million at 6 and 24 h
(Figure 2C), which is at least 10 times more than the estimated
100,000 copies per cell for all mature miRNAs in HeLa cells and
mouse embryonic stem cells (Calabrese et al., 2007; Janas et al.,
2012). Interestingly, the high molecular weight RNA species were
already present in direct spike-in miRNA mimic samples, but
appeared in higher amounts in miRNA mimic-transfected cells,
suggesting that they were generated by both the manufacturing
process and cellular processes (Figure 2C). The most abundant
ones were in the size range of 25–50 nt (Figures 2A,C), which we
decided to focus on in the following study.
Since cel-mir-67 is a C. elegans miRNA that has no homolog
in mammalian species, we decided to perform the same
experiments using microRNA-17∼92 (miR-17∼92), a miRNA
cluster encoding six mature miRNAs (miR-17, miR-18a, miR-
19a, miR-20a, miR-19b, and miR-92). miR-17∼92 is broadly and
abundantly expressed in mammalian tissues and cell lines (Lu
et al., 2005; Kuchen et al., 2010). Mouse genetic studies from
us and other investigators have demonstrated essential functions
of these miRNAs in a large diversity of biological processes (He
et al., 2005; Lu et al., 2007; Ventura et al., 2008; Xiao et al., 2008;
Conkrite et al., 2011; De Pontual et al., 2011; Jiang et al., 2011;
Baumjohann et al., 2013; Bian et al., 2013; Danielson et al., 2013;
Jin et al., 2013; Kang et al., 2013; Khan et al., 2013). Importantly,
a 3–5-fold increase in its expression in B cells was sufficient
to drive lymphoma development (Jin et al., 2013, 2014). In
experiments similar to those of cel-mir-67, we mixed the six miR-
17∼92 miRNAs at equal molar concentrations and transfected
HeLa cells with a total concentration of 100 nM (16.7 nM for
each miRNA). Interestingly, this led to accumulation of not
only mature miR-17∼92 miRNAs, but also high molecular
weight RNA species similar to those observed for cel-mir-
67 (Figures 2A, 3A), suggesting that the generation of high
molecular weight RNAs is a general phenomenon associated
with transient transfection of synthetic miRNA mimics. It is
noteworthy that these miRNAmimics exhibited exactly the same
behavior despite the fact that they were synthesized by two
different companies (Dharmacon and Shanghai GenePharma) in
two different countries.
Our previous study demonstrated that the miR-17∼92 family
miRNAs are expressed at similar levels in HeLa cells and in
murine B cells (Xiao et al., 2008). When transfected into HeLa
cells at individual concentrations of 16.7 nM, they achieved a
10-20-fold (miR-92) or 200–400-fold (miR-17/20a, 18a, 19a/19b)
overexpression (Figure 3), far exceeding the 3–5-fold increase
that was sufficient to drive B cell lymphoma development in
mice (Jin et al., 2013), as well as the 2–36-fold increase found
in biopsies of human Burkitt’s lymphomas, which consistently
exhibit activation of the c-Myc-miR-17∼92 axis (Schmitz et al.,
2012). Studies from us and other investigators estimated that
miR-17∼92 miRNAs are expressed at a few thousand copies
per cell (Mukherji et al., 2011; Bosson et al., 2014). Therefore,
transient transfection at individual concentrations of 16.7 nM
brings the total amount of miR-17∼92 miRNAs to a million
copies per cell, which is similar to the estimated copy number
of cel-mir-67 when transfected at 100 nM (Figure 2C). Taken
together, these results demonstrate that commonly used transient
transfection concentrations (25 and 100 nM) bring cellular
miRNAs to supraphysiological levels and, thereby, may cause
saturation of the miRNA system.
Transfection of miRNA Mimics at Low
Concentrations is Sufficient to Achieve
Pathological miRNA Levels
To imitate miR-17∼92 expression levels found in the biopsies
of human Burkitt’s lymphomas (2–36-fold) (Schmitz et al.,
2012), we transfected an equal molar mix of miR-17, 19a,
20a, and 19b at 0.5nM for each miRNA. miR-17 and miR-
20a belong to the miR-17 family, while miR-19a and miR-19b
belong to the miR-19 family. As members in these families share
identical seed regions and differ from each other by only 1–
3 nucleotides, they cannot be easily distinguished by Northern
blot. Therefore, we mixed probes for members of each family
together and performed Northern blot with the mixed probes.
The transfection concentration for each family was 1 nM, which
is 25–100-fold lower than what was commonly used in the
literature (Lim et al., 2005; Grimson et al., 2007; Baek et al.,
2008; Selbach et al., 2008; Guo et al., 2010). At this transfection
concentration, the cellular levels of miR-17 and miR-19 family
miRNAs reached 10-fold of endogenous levels in 30min post-
transfection, peaked around 23-fold at 3–6 h, and started to
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FIGURE 2 | Northern blot analysis of cel-mir-67 and endogenous miRNAs in HeLa cells transiently transfected with 100nM cel-mir-67. HeLa cells were
transfected with 100 nM unconjugated cel-mir-67 and analyzed by Northern blot to detect cel-mir-67 (A) and endogenous miR-17, miR-18a, miR-19b, miR-92a, and
miR-16 (B). Arrows indicate mature cel-mir-67 and brackets indicate high molecular weight RNA species. L1236, a human Hodgkin’s lymphoma cell line that
expresses 2–3-fold more miR-17∼92 than HeLa cells, was used as a universal reference throughout the manuscript. (C) The copy numbers of cel-mir-67 in
transfected HeLa cells were estimated by comparing to graded amounts of the same miRNA mimic loaded directly into the Northern blot gel. Three different
exposures of the same blot showed that the high molecular RNA species were generated by both the manufacturing process (before transfection) and cellular
processes (after transfection), cpc, copies per cell. AU, arbitrary unit. The amount of transfected mir-cel-67 was estimated by comparing the mature signals of
transfected mir-cel-67 to the spiked-in cel-mir-67.
decline afterwards (Figure 4A). Similar to transient transfection
at higher concentrations (Figures 2, 3), we still observed high
molecular weight RNA species in transfected cells, though they
represented a much lower percentage of Northern blot signals
(Figure 2C). To directly compare the degree of overexpression
achieved by this low transfection concentration with miR-17∼92
overexpression in lymphomas and leukemias, we measured the
endogenous miR-17∼92 levels in nine human lymphoma and
leukemia cell lines. The maximal miR-17∼92 expression level in
these cell lines was about 10-fold of that found in naïve B cells
(Figures 4B,C), consistent with the 2–36-fold overexpression
found in biopsies from human Burkitt’s lymphoma patients
(Schmitz et al., 2012) (Figure 4C). Importantly, none of these cell
lines express the high molecular weight RNA species found in
transiently transfected HeLa cells (Figure 4B). Collectively, these
results demonstrate that transient transfection with 1 nMmiRNA
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A
B
FIGURE 3 | Northern blot analysis of miR-17∼92 miRNAs in HeLa cells transiently transfected with miR-17∼92 mimics. (A) HeLa cells were transfected
with an equal molar mixture of miR-17, 18a, 19a, 20a, 19b, and 92a (16.7 nM each with a total transfection concentration of 100 nM) and analyzed by Northern blot to
detect these miRNAs. Mixed probes were used for the detection of miRNAs in each subfamily. Numbers below each blot image indicate fold-induction of mature
miRNAs (∼22 nt). Mature miRNA expression levels in non-transfected HeLa cells were set as 1. L1236 cells and HeLa cells transfected with 100 nM cel-mir-67 (Mock)
were used as controls. Small boxes in the upper left corner of Northern blots are longer exposures to show mature miRNAs in the same lanes. (B) Quantification of
mature miRNA levels in (A). Endogenous miR-18a in Replicate 1 was not detectable and was excluded from quantification.
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mimics is sufficient to achieve expression levels comparable to
those found in primary human lymphomas and leukemia, and
minimizes the generation of high molecular weight RNA species.
Lentiviral Transduction, Plasmid
Transfection and Transgene Achieve
Physiological miRNA Overexpression and
Efficiently Suppress Target Gene
Expression
Other commonly used methods to ectopically express miRNAs
are through lentiviral infection, retroviral infection, plasmid
transfection and transgene expression. We next examined
miRNA expression by these methods, focusing on expression
levels and the appearance of high molecular weight RNA
species. We have previously generated a conditional miR-
17∼92 transgene (termed miR-17∼92 Tg), whose expression
can be turned on in B cells by CD19-Cre, and showed
that the resulting transgenic mice (TG) developed lymphomas
with high penetrance (Jin et al., 2013). We examined miR-
17∼92 expression in primary B cells isolated from these mice
in the presence and absence of stimulation. As shown in
Figure 5A, transgenic miR-17∼92 expression led to a 2–6-
fold increase in the amounts of these miRNAs. On the other
A
C
B
FIGURE 4 | Northern blot analysis of miRNAs in HeLa cells transiently transfected with low concentrations of miR-17∼92. (A) HeLa cells were transfected
with an equal molar mixture of miR-17, 19a, 20a, 19b (0.5 nM each with a total transfection concentration of 2 nM) and analyzed by Northern blot to detect these
miRNAs. Mixed probes were used for the detection of miRNAs in each family. Numbers below blots indicate fold increase of mature miRNA levels. Mature miRNA
expression levels in non-transfected HeLa cells were set as 1. (B) Northern blot analysis of endogenous miR-17∼92 levels in nine human lymphoma or leukemia cell
lines. Mixed probes were used for the detection of miRNAs in each family. Numbers below blots indicate fold increase of mature miRNA levels. Mature miRNA
expression levels in L1236 were set as 1. (C) Summary of miR-17 expression levels in samples used in this study. Results for primary B cells, lentivirally transduced
(LV-17∼92) and plasmid transfected (Plasmid-17∼92) HeLa cells were from Figure 5. Red and blue dashed lines indicate the maximal and mean miR-17 expression
levels in human Burkitt’s lymphoma patients, respectively (Schmitz et al., 2012). Mature miR-17 expression level in naïve B cells was set as 1.
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hand, stable transduction of HeLa cells with a miR-17∼92
expressing lentivirus at MOI (multiplicity of infection) of
10–100 led to a 2–5-fold, while transient transfection of the
same cells with a miR-17∼92 expressing plasmid led to a 2-
fold increase in the expression of these miRNAs. Therefore,
these three methods achieved similar fold increases in miR-
17∼92 expression (Figures 5A–C), which were in the same
range as that observed in human lymphoma and leukemia cell
lines (Figure 4C). Importantly, in none of these experimental
conditions did we see the high molecular weight RNA species
that are characteristic of transient transfection of miRNAmimics
(Figures 5A–C). Lentiviruses, plasmids, and transgenes used
in this study were designed to include pri-miRNAs and their
flanking regions (Xiao et al., 2008), which are critical for their
biogenesis and expression (Guil and Cáceres, 2007; Du et al.,
2015). In addition, transgenes and lentiviruses are integrated
into the host cell genome, and mature miRNA production by
these methods likely follows the same biogenesis pathway as
endogenous miRNAs. This may explain the limited fold increase
achieved by these methods, as well as the absence of high
molecular weight RNA species.
Next we examined the effect of lentivirally expressed miR-
17∼92 on its target gene expression by Western blot. Similar to
transgenic miR-17∼92 expression in B cells (Jin et al., 2013), a
2–5-fold increase in miR-17∼92 expression in HeLa cells was
sufficient to suppress the protein output of previously validated
miR-17∼92 target genes (Phlpp2, Pten, and Bim) (Figure 5E)
(Ventura et al., 2008; Xiao et al., 2008; Rao et al., 2012; Jin
et al., 2013; Kang et al., 2013; Xu et al., 2015). The percentage
reduction in target gene protein levels was similar to, or even
higher than, that achieved by transgenic miR-17∼92 expression
(Figures 5D–F), which is able to drive lymphoma development
with high incidence (Jin et al., 2013). We also examined
the effect of transgenic and lentiviral miR-17∼92 expression
on target gene mRNA levels. While transgenic miR-17∼92
expression predominantly suppressed target gene expression at
the translation level (Figure 5D), the effect of lentiviral miR-
17∼92 expression was target gene-specific: it suppressed the
expression of Phlpp2 and Bim by translation repression, and
Pten mainly through mRNA degradation (Figure 5F). Taken
together, in spite of some minor differences, miRNA expression
by lentivirus and transgene achieves similar expression levels and
exerts comparable effects on target genes.
Transfection of miRNA Mimics at High
Concentrations Causes Non–specific
Changes in Gene Expression
We then examined the effect of transiently transfected miR-
17∼92 mimics on the same group of target genes. Upon
transfection with 100 nM miR-17∼92 mimics, the mRNA levels
of all three target genes were reduced by 60∼80% at 30min
post-transfection, and started to recover after 12 h (Figure 6A).
Surprisingly, transient transfection of cel-mir-67 mimic caused
similar degree of mRNA reduction for the same set of genes,
and their recovery was even slower (Figure 6A). In addition,
transient transfection of both miR-17∼92 and cel-mir-67 mimics
led to reduction in protein levels of these target genes, though
the kinetics differs for different target genes (Figures 6B,C). This
is unexpected because cel-mir-67 bears no sequence similarity
to any mammalian miRNAs including miR-17∼92. We searched
these target mRNAs for potential cel-mir-67 binding sites and
found only one 7-mer site in the Pten 3′UTR and none in
the Bim and Phlpp2 mRNAs. We cannot fully exclude the
possibility that the reduction in the Pten mRNA and protein
levels was mediated by the 7-mer cel-mir-67 binding site in its
3′UTR, but the decrease in Bim and Phlpp2 expression was likely
due to non-specific effects. Therefore, transient transfection of
miRNA mimics at high concentrations (100 nM) can alter gene
expression in a non-specific manner.
Transfection of miRNA Mimics Does Not
Induce Interferon Responses
Previous studies showed that double-stranded RNAs (dsRNAs)
induce innate immune responses, especially the interferon
responses (Wang and Carmichael, 2004), which may lead to the
non-specific gene suppression caused by transient transfection
of miRNA mimics. We investigated several innate immune
responsive genes whose expressions are highly induced by long
dsRNAs, including interferons (IFNs: Ifna2 and Ifnb1), an
interferon regulatory factor (IRF: Irf7), and interferon-stimulated
genes (ISGs: Mx1, Oas1, Isg15) (Figures 7A–C) (Dewitte-Orr
et al., 2009). We also examined Tlr3 and Eif2ak2, whose
expression is specifically induced by transient transfection of 27–
29 bp long dsRNAs (Reynolds et al., 2006) (Figure 7D). Among
all genes examined, only interferon-α2 (Ifna2) and interferon-β1
(Ifnb1) were induced at early time points of transfection, but their
induction was quickly resolved (Figure 7A). Importantly, the
transient induction of IFNs did not trigger the expression of other
innate immune response genes. On the contrary, most of the
dsRNA-responsive genes examined were suppressed by transient
transfection of miRNA mimics (Figures 7B–D). Therefore, it is
unlikely that non-specific suppression of target gene expression
caused by transient transfection of high concentration miRNA
mimics is due to induction of innate immune responses.
Transfection of miRNA Mimics at Low
Concentrations Fails to Suppress Target
Gene Expression
We next examined the effect of transient transfection of
low concentrations of miRNA mimics on target genes. For
this purpose, we transfected HeLa cells with a mixture of
miR-17∼92 miRNA mimics at 0.5 nM for each member (3 nM
in total) and measured target gene mRNA and protein levels.
Importantly, this low concentration transfection achieved a
4–20-fold increase in miR-17∼92 expression (Figure 4A). This
amount of overexpression was able to suppress target gene
expression when introduced by transgene, lentivirus, or plasmid
transfection (Figure 5D) (Xiao et al., 2008; Jin et al., 2013;
Kang et al., 2013). In stark contrast, the 4–20-fold increase in
miR-17∼92 expression brought about by transient transfection
of low concentrations of miRNA mimics was not sufficient to
suppress target gene expression (Figures 8A–C). Therefore,
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FIGURE 5 | The effect of transgenic and lentiviral miR-17∼92 expression on target genes. (A–C) Northern blot analysis of miR-17∼92 expression. Primary B
cells were purified from CD19-Cre (Control) and miR-17∼92 Tg/Tg; CD19-Cre (TG) mice, stimulated in vitro for indicated amounts of time (A). HeLa cells were stably
transduced with control or miR-17∼92 expressing lentiviruses at indicated MOI (Multiplicity of infection) (B). HeLa cells were transfected with empty plasmid or
(Continued)
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FIGURE 5 | Continued
miR-17∼92-expressing plasmid (Plasmid-miR-17∼92) and harvested at indicated time points (C). Numbers below blots indicate miR-17∼92 expression normalized
to U6. miRNA/U6 ratios in naïve control B cells (A), non-transduced HeLa cells (B), and empty plasmid transfected HeLa (C) were arbitrarily set as 1. (D)
Quantification of protein and mRNA levels of target genes in primary B cells (n = 4). The representative western blot results were presented previously (Jin et al.,
2013). (E) Western blot analysis of miR-17∼92 target gene expression in lentivirally transduced HeLa cells. Different MOI are indicated. Numbers below blots indicate
target gene expression normalized to β-Actin. The ratios in parental HeLa cells were arbitrarily set as 1. (F) Quantification of protein and mRNA levels of target genes in
lentivirally transduced HeLa cells. (D–F) Target gene protein and mRNA levels were determined by Western blot and qRT-PCR, respectively.
FIGURE 6 | The effect of high concentration transient transfection on target gene expression. HeLa cells were transiently transfected with miRNA mimics.
Target gene mRNA and protein levels were determined by qRT-PCR and Western blot at indicated time points and normalized to β-Actin. The target gene/β-Actin
ratios of non-transfected HeLa cells were arbitrarily set as 1 (dashed line). miR-17∼92 mix 100 nM contains an equal molar mixture of miR-17∼92 miRNAs at 16.7 nM
for each miRNA with a total concentration of 100 nM. (A,B) Summary of mRNA and protein quantification results. (C) Representative Western blots.
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FIGURE 7 | The effect of high concentration transient transfection on innate immune responses. The mRNA levels of genes involved in innate immune
response to dsRNA were determined by qRT-PCR and normalized to β-Actin. The target gene/β-Actin ratios of non-transfected HeLa cells were arbitrarily set as 1
(dashed line). Type I interferons (A), interferon regulatory factors (B), interferon stimulated genes (C) and genes specifically responding to 27–29 nt long dsRNA (D)
were investigated.
transient transfection of miRNA mimics at high concentrations
led to non-specific alterations in gene expression, while at low
concentrations was not effective in suppressing target gene
expression.
Supraphysiological Overexpression and
High Molecular Weight RNA Species is a
General Phenomenon Associated with
miRNA Mimic Transfection
To determine whether our observations are a general
phenomenon of transient transfection of miRNA mimics,
we investigated miR-155, a lymphocyte specific miRNA. miR-155
is expressed at relatively low levels in naïve B cells, and is
significantly induced upon B cell activation (Rodriguez et al.,
2007; Thai et al., 2007). Similar to miR-17∼92, miR-155 is
frequently up-regulated in human B cell lymphomas (Eis et al.,
2005; Rai et al., 2008), and transgenic expression of miR-155
is sufficient to drive B cell lymphoma development in mice
(Costinean et al., 2006). In addition, transient transfection of
miR-155 mimic into HeLa cells was used as a model system to
study miRNA mechanism of action in mammalian cells (Guo
et al., 2010). Under the same experimental conditions, the
peak cellular concentrations of miR-155 reached 200–400-fold
of that found in activated B cells (Figure 9A). This level of
overexpression was about 50-fold of that achieved by transgenic
miR-155 expression in B cells, which was sufficient to drive
lymphoma development (Costinean et al., 2006). Similar to
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FIGURE 8 | The effect of low concentration transient transfection on target gene expression. HeLa cells were transfected with an equal molar mixture of
miR-17∼92 miRNAs at 0.5 nM for each miRNA with a total concentration of 3 nM. Target gene mRNA and protein levels were determined by qRT-PCR and Western
blot at indicated time points and normalized to β-Actin. The target gene/β-Actin ratios of non-transfected HeLa cells were arbitrarily set as 1 (dashed line). (A,B)
Summary of mRNA and protein quantification results. (C) Representative Western blots.
miR-17∼92 and cel-mir-67 mimic, transient transfection of
miR-155 mimic also caused accumulation of high molecular
weight RNA species (Figure 9A). We next examined the
endogenous levels of miR-155 in our panel of nine human
lymphoma and leukemia cell lines. As shown in Figures 9B,C,
the highest miR-155 expression in these cell lines was a few
fold of that found in activated B cells. Consistent with miR-
17∼92 results, there was no miR-155-specific high molecular
weight RNA species in activated B cells, transgenic B cells,
and lymphoma and leukemia cells (Figures 9A,B). Lastly, we
examined the effect of transgenic miR-155 expression on its
functional target gene, Ship1 (O’connell et al., 2009; Pedersen
et al., 2009). While a previous study showed that the Ship1
protein was upregulated in activated B cells deficient of miR-155
(O’connell et al., 2009), it was significantly downregulated
in miR-155 transgenic (termed 155TG) B cells, accompanied
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A
B
C
D
FIGURE 9 | The effect of transient transfection and transgenic expression of miR-155. (A) Northern blot analysis of miR-155 expression in HeLa cells
transiently transfected with a miR-155 mimic, and in primary B cells from wild type and miR-155 transgenic mice (155TG). Two different exposures of the same blot
are included. (B) Northern blot analysis of endogenous miR-155 expression in nine human lymphoma or leukemia cell lines. (C) Summary of miR-155 Northern blots
in (A,B). Mature miR-155 expression in in vitro activated B cells was arbitrarily set as 1 in (A–C). Red and blue dashed lines in (C) indicate the maximal and mean
miR-155 expression levels in human lymphoma patients, respectively. This was estimated from absolute copy numbers of miR-155 in activated B cells (data not
shown) compared to that in lymphoma patients (Eis et al., 2005). (D) Ship1 expression in miR-155 transgenic B cells. Upper panel, a representative Western blot.
Lower panel, bar graphs summarizing Ship1 protein and mRNA levels in miR-155 transgenic B cells as determined by Western blot and Microarray. Each circle
indicates an independent biologic sample.
by a marginal reduction in its mRNA level (Figure 9D).
These results suggest that the predominant effect of miR-
155 on Ship1 is exerted at the translation level (Figure 9D).
Taken together, transient transfection of a miR-155 mimic
at 100 nM led to a few hundred fold increase in the mature
miRNA level and accumulation of high molecular weight
RNA species, which are similar to miR-17∼92 and cel-mir-67
mimics.
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FIGURE 10 | Transient transfection of miRNA mimics led to the accumulation of mutated miRNAs and unnatural miRNA passenger strands. (A)
Non-transfected HeLa cells and HeLa cells transfected with miR-17∼92 miRNA mimics were analyzed by small RNA deep sequencing at 6 h after transfection (the
same sample as in Figure 3A, replicate 1, miR-17∼92 mix 100 nM). Mature miRNAs, antisense miRNAs, and their mutant forms with abundance higher than 0.1% of
(Continued)
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FIGURE 10 | Continued
total reads are listed. Note that non-transfected HeLa cells do not express antisense miRNAs or mutant miRNAs at levels higher than this cut off, while HeLa cells
transfected with miR-17∼92 mix contain many of these species. Antisense miR-17 sequences (marked in red) are perfectly complementary to miR-17, and differ from
miR-17*, the endogenous form of miR-17 passenger strand, by a few nucleotides. miR-17∼92 miRNAs are marked in green, and their mutant forms are marked in
orange. Sequences of the latter are included. Red notches indicate the location of deletion, with deleted nucleotides presented at the right. (B) Northern blot analysis
of antisense miR-17 (as indicated in the right panel of A) in transfected HeLa cells. The blot from Figure 3A Replicate 1 was hybridized with a probe specific for
antisense miR-17.
Mutated Guide Strands and Unnatural
Passenger Strands Accumulate in miRNA
Mimic Transfected Cells
We next performed small RNA deep sequencing analysis of non-
transfected HeLa cells and HeLa cells transiently transfected
with miR-17∼92 miRNA mimics to investigate the identity of
high molecular weight RNA species. Our library preparation
strategy allowed us to capture both mature miRNAs and the
high molecular weight RNA species. The total read counts
of non-transfected HeLa cells (4.14 × 106) and miR-17∼92
miRNA mimics-transfected HeLa cells (4.08 × 106) were almost
identical, so that we can directly compare the read counts of
individual RNA species in these two samples. Consistent with the
Northern blot results (Figure 3), there was a significant increase
in the read counts for miR-17∼92 miRNAs in miRNA mimics-
transfected HeLa cells (Figure 10A). Surprisingly, mutated forms
of miR-17∼92 miRNAs were present in high abundance in
miRNA mimics-transfected HeLa cells, while completely absent
in non-transfected HeLa cells. Most of the mutations were
single nucleotide deletion, but trimmed forms were also found.
In addition, sequences perfectly antisense to mature miR-17
(termed antisense miR-17) were found in high abundance,
probably arising from the passenger strand of the miR-17 mimic.
These antisense miR-17 sequences differ from miR-17∗, the
endogenous miR-17 passenger strand, by a few nucleotides
(Figure 10A). The presence of antisense miR-17 (unnatural
miR-17∗) in transfected HeLa cells was confirmed by Northern
blot analysis (Figure 10B). We speculate that the mutated miR-
17∼92 miRNAs, together with antisense miR-17, may cause the
non-specific alterations in gene expression in miRNA mimics-
transfected HeLa cells (Figure 6). In line with this, a recent report
showed that passenger strands derived from miRNA mimics
accumulated in transiently transfected cells and were potent in
suppressing their target genes (Søkilde et al., 2015).
Characterization of High Molecular Weight
RNA Species in miRNA Mimic Transfected
Cells
Since miR-17∼92 miRNA mimics were frequently mutated and
trimmed in transfected cells, and probes used in our Northern
blot experiments can potentially hybridize with RNA species with
imperfect complementarity, we searched the deep sequencing
data for high molecular weight RNA species containing miR-
17∼92 miRNA sequences, allowing a few nucleotide mismatches.
Consistent with Northern blot results, miR-17∼92 miRNA
mimics-transfected HeLa cells did contain high molecular
weight RNA species harboring individual miR-17∼92 miRNA
sequences. The length distribution of these long reads is
consistent with that revealed byNorthern blot (Figures 3A, 11A),
and they are absent in non-transfected HeLa cells (Figure 11B).
Most of these long reads contain non-templated addition of
nucleotides (tailing) to the 5′ or 3′ end of miR-17∼92 miRNAs.
In addition, miRNA concatemers, hybrids between miR-17∼92
miRNAs and other endogenous miRNAs, and polyadenylated
miR-17∼92 miRNAs were also identified, but their abundance
was much lower than those with 5′- and 3′-end tailing
(Figures 11B,C). Therefore, our small RNA deep sequencing
analysis confirmed the accumulation of high molecular weight
RNA species in miRNA mimics-transfected cells, which were a
heterogeneous mixture of several classes of RNA species that
may be generated by concatemerization, 5′- and 3′-end tailing of
miRNA mimics.
DISCUSSION
The present study demonstrates that transient transfection
of miRNA mimics into HeLa cells using a commonly used
protocol and transfection concentration led to accumulation
of high molecular weight RNA species, a few hundred fold
increase in mature miRNA levels, and an estimated cellular
concentration of 1 million copies per cell, which is 10 times of
the whole mature miRNA pool in a cell. In contrast, transgenic
expression, plasmid transfection and lentiviral transduction of
the same miRNAs achieved less than 10-fold overexpression,
which was sufficient to suppress target gene expression and
drive lymphoma development. In addition, the levels of
endogenous overexpression of these miRNAs in a panel of
human lymphoma and leukemia cell lines were similar to
these achieved by transgene-, plasmid-, and lentivirus-driven
expression, with no accumulation of high molecular weight
RNA species in any of these four experimental conditions.
Furthermore, transient transfection of miRNA mimics at high
concentrations altered gene expression in a non-specific manner,
while at low concentrations failed to efficiently suppress target
gene expression. The non-specific effects of miRNA mimics
may be caused by the supraphysiological levels of mature
miRNAs and the accumulation of mutated guide strands,
unnatural forms of passenger strands, and high molecular weight
RNA species generated by concatemerization, 5′- and 3′-end
tailing of miRNA mimics. These findings call into question the
physiological relevance of the large volume of studies employing
the transient transfection approach to investigate the functions
and mechanisms of individual miRNAs.
A case in point comes from recent studies employing
the transient transfection approach which concluded that
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FIGURE 11 | Characterization of high molecular weight RNA species. (A) Length distribution of high molecular weight RNA species identified in the small RNA
deep sequencing data of Figure 10. Each peak represents the read count of high molecular weight RNA species of indicated length. SNORD29 contains sequence
region highly homologous to miR-19b and is detected in both non-transfected and miR-17∼92 mix-transfected HeLa cells. (B) Fold change of high molecular weight
RNA species in miR-17∼92 mix-transfected HeLa cells. The abundance in non-transfected HeLa cells was arbitrarily set as 1. RNA species of 30–60 nt are included in
the calculation to exclude SNORD29. The relative abundance of concatemer, 5′-tailing, and 3′-tailing are presented in pie charts. (C) Representatives of high
molecular weight RNA species, using miR-19-containing sequences as examples.
mammalian miRNAs predominantly act to decrease target
mRNA levels rather than decreasing translation efficiency (Guo
et al., 2010). Re-analysis of this data set revealed that translation
repression precedes mRNA degradation upon miRNA targeting
(Larsson and Nadon, 2013). The latter finding was consistent
with previous studies of miR-430 during the early stage of
embryogenesis in zebrafish. miRNAs are essentially absent
from fertilized zebrafish eggs (Chen et al., 2005). Around 4 h
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post-fertilization (4 hpf), a zebrafish-specific miR-430 family is
expressed (Chen et al., 2005; Giraldez et al., 2006). This miRNA
family is very unusual in that it has ∼100 copies of genes
distributed over three clusters in the zebrafish genome (Thatcher
et al., 2008). The mature miR-430 miRNAs reach millions of
copies in a few hours after fertilization and remain as the only
miRNAs expressed until 12 hpf, when a few other miRNAs begin
to be expressed (Chen et al., 2005). Ribosome profiling studies
showed that miR-430 miRNAs promote translation repression
followed by deadenylation and degradation of maternal mRNAs
(Bazzini et al., 2012). The temporal and quantitative nature
of miR-430 induction is unique for the early embryogenesis
of zebrafish. Extensive deep sequencing analysis of mammalian
tissues and cells has, to date, not found any miRNAs with similar
abundance and dominance in any cellular contexts examined
(Lu et al., 2005; Kuchen et al., 2010). It has been estimated
that mammalian cells often express 100–200 different species
of miRNAs (Kuchen et al., 2010), with a total amount of 1–2
×105 copies of mature miRNAs in a cell (Calabrese et al., 2007;
Janas et al., 2012). The most abundant miRNAs are expressed
at the level of ∼2 × 104 copies per cell (Neilson et al., 2007;
Kuchen et al., 2010). Therefore, it is very unlikely that the
million-copy-per-cell expression level of miR-430 in zebrafish
embryos, as well as those achieved by transient transfection
of high concentrations of miRNA mimics into mammalian
cells, represents any mammalian miRNAs under physiological
or pathological conditions. The translation repression followed
by mRNA degradation model of miRNA mechanism of action,
which was originally proposed based on the study of zebrafish
miR-430, may not be universally applicable to mammalian
miRNAs under physiological conditions. In line with this, an
extensive survey of functionally relevant target genes validated
in 77 miRNA mutant mice showed that the predominant
mode of target gene suppression by miRNA is cell type-,
miRNA- and target gene-dependent, with varying contributions
from translation repression and mRNA degradation, suggesting
that different miRNA-target gene interactions are governed by
different mechanisms (Jin and Xiao, 2015).
The high molecular weight RNA species present in cells
transfected with high concentrations of miRNA mimics are of
great interest. Our small RNA deep sequencing analysis showed
that they are a heterogeneous mixture of several classes of RNA
species that are generated by concatemerization, 5′- and 3′ -end
tailing of miRNA mimics. Northern blot analysis revealed that
low concentrations of these high molecular weight RNA species
were already present in miRNAmimics before transfection, likely
generated during the manufacturing process. Their amounts
were drastically increased upon transfection into HeLa cells,
suggesting the existence of cellular mechanisms that convert
miRNA mimics into longer forms. Previous studies have shown
frequent modifications of endogenous miRNAs, including RNA
editing, RNA methylation, uridylation, and adenylation (Ameres
and Zamore, 2013; Ha and Kim, 2014). In addition, extensive
complementarity between a target mRNA and an Ago-bound
miRNA triggers miRNA tailing and trimming, leading to the
generation of high molecular weight RNA species in the same
size range as these observed in this study (Ameres et al., 2010).
The exact molecular pathways that convert miRNA mimics
into high molecular weight RNA species and the functions of
these pathways under physiological and pathological conditions
warrant future investigation.
Based on our observations, several recommendations can
be made for miRNA studies in the future. First, lentiviral,
retroviral, and genetic approaches are preferred over transient
transfection to alter cellular concentrations of individual
miRNAs. As lentivirus, retrovirus and transgenes are integrated
into the genome of a cell, their encoded miRNAs will likely
follow the same biogenesis pathway and adopt the same
mechanism of action of endogenous miRNAs. miRNA functions
and mechanisms deduced from experiments employing these
approaches will likely be physiologically relevant. Second, if
transient transfection is the onlymethod available to altermiRNA
expression levels then miRNA mimics should be introduced
into cells at transfection concentrations much lower than the
25 or 100 nM that are commonly used. Ideally, the cellular
concentration of transfected miRNAs should be optimized by
Northern blot and compared with that of primary cells in
which these miRNAs are known to function. Supraphysiological
expression levels and the appearance of high molecular weight
RNA species, whose function is still unclear, should be avoided.
Third, a control transfection with the same concentration of
an unrelated miRNA mimic is essential for any miRNA mimic
transfection experiments, as the transfection of miRNA mimics
per se may alter gene expression in a non-specific manner. To
reveal miRNA-specific effects, a seed-mutant form of the same
miRNAmimic is highly recommended (Lim et al., 2005). Last, the
translation repression followed by mRNA degradation model of
miRNAmechanism of action should be interpreted with caution,
as it remains to be investigated whether mammalian miRNAs
expressed at physiological levels employ similar mechanisms
of action (Jin and Xiao, 2015). Increasing numbers of mutant
mouse strains harboring gain- and loss-of function mutations for
individual miRNA genes are being generated (Olive et al., 2015).
Primary cells from these animal models are ideal for studying
miRNA mechanisms of action in the future.
During the revision of our manuscript, another cautionary
tale on miRNA mimics was published, reporting that transient
transfection of miRNA mimics may cause considerable side
effects due to passenger strand (miRNA∗) loading to AGO
(Søkilde et al., 2015). Their study and our study investigated
different aspects of miRNA mimics, and together provided a
list of potential artifacts researchers should carefully consider,
control, and avoid.
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